Oncolytic herpes simplex virus interactions with the host immune system.

Area of Science:

• Virology
• Immunology
• Oncology

Background:

• Oncolytic viruses (OVs), including oncolytic herpes simplex virus (oHSV), are engineered to target and destroy cancer cells selectively.
• OV infection triggers host immune responses, influencing therapeutic outcomes.
• The tumor microenvironment and immunosuppression complicate the host-oHSV interaction.

Purpose of the Study:

• To review the complex host responses to oHSV therapy.
• To discuss the immune evasion mechanisms employed by HSV.
• To analyze the impact of these mechanisms on oHSV efficacy in cancer treatment.

Main Methods:

• Literature review of studies on oncolytic viruses and herpes simplex virus.
• Analysis of host-virus interactions in the context of cancer therapy.
• Examination of viral immune evasion strategies.

Main Results:

• oHSV therapy induces both anti-viral and anti-tumor immune responses.
• HSV possesses multiple sophisticated mechanisms to evade host immune surveillance.
• Tumor microenvironment and immunosuppression significantly modulate the host response to oHSV.

Conclusions:

• Understanding HSV immune evasion is crucial for optimizing oHSV therapy.
• Modulating host-virus interactions could enhance the effectiveness of oHSV in cancer treatment.
• Further research into HSV evasion strategies is needed to improve oncolytic virotherapy.